Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators

  • Eur J Med Chem. 2018 Nov 5:159:90-103. doi: 10.1016/j.ejmech.2018.09.053.
Fangchao Bi  1 ,  Di Song  1 ,  Nan Zhang  1 ,  Zhiyang Liu  1 ,  Xinjie Gu  1 ,  Chaoyu Hu  1 ,  Xiaokang Cai  1 ,  Henrietta Venter  2 ,  Shutao Ma  3
Affiliations
  • 1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan, 250012, China.
  • 2. School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, SA, 5000, Australia.
  • 3. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan, 250012, China. Electronic address: [email protected].
Abstract

Antibiotic resistance among clinically significant Bacterial pathogens is becoming a prevalent threat to public health, and new Antibacterial agents with novel mechanisms of action hence are in an urgent need. Utilizing computational docking method and structure-based optimization strategy, we rationally designed and synthesized two series of isoxazol-3-yl- and isoxazol-5-yl-containing benzamide derivatives that targeted the Bacterial cell division protein FtsZ. Evaluation of their activity against a panel of Gram-positive and -negative pathogens revealed that compounds B14 and B16 that possessed the isoxazol-5-yl group showed strong Antibacterial activity against various testing strains, including methicillin-resistant Staphylococcus aureus and penicillin-resistant S. aureus. Further molecular biological studies and docking analyses proved that the compound functioned as an effective inhibitor to alter the dynamics of FtsZ self-polymerization via a stimulatory mechanism, which finally terminated the cell division and caused cell death. Taken together, these results could suggest a promising chemotype for development of new FtsZ-targeting bactericidal agent.

Keywords
Antibacterial activity; FtsZ inhibitor; Isoxazole-containing benzamide; Molecular docking analysis; Structure-based optimization.
Products